Abstract
Despite a broad knowledge base about the pathology of schizophrenia, albeit fragmented and often inconsistent, no theme has emerged to link the illness with its molecular pathophysiology. There is insufficient certainty and consistency of findings to identify the critical molecular target on which to base therapeutic discovery. The most limiting aspect of schizophrenia therapeutics is this lack of critical knowledge with respect to its target pathophysiology, on which therapeutic strategies could be developed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
Altshuler LL, Conrad A, Kovelman JA, Scheibel A. Hippocampal pyramidal cell orientation in schizophrenia: a controlled neurohistologic study of the Yakovlev collection. Arch Gen Psychiatry 1987;44(12): 1094–1098.
Andreasen NC, Arndt S, Swayze VW II, et al. Abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994;266(5183):294–298.
Andreasen NC, Rezai K, Alliger RJ, et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch Gen Psychiatry 1992;49:943–958.
Arolt V, Lencer R, Nolte A, Pinnow M, Schwinger E. Eye tracking dysfunction in families with multiple cases of schizophrenia. Eur Arch Psychiatry Clin Neurosci 1996;246(4):175–181.
Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990;147(11):1457–1462.
Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992; 12(3):924–929.
Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 1990;35(1):1–13.
Braff DL. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 1993;19(2):233–259.
Braff DL, Heaton R, Kuck J, et al. The generalized pattern of neuropsy-chological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin card sorting test results. Arch Gen Psychiatry 1991;48(10):891–898.
Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 1992;49(12):921–926.
Buchsbaum MS, DeLisi LE, Holcomb HH, et al. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 1984;41:1159–1166.
Chen Y, Nakayama K, Levy DL, Matthysse S, Holzman PS. Psychophysical isolation of a motion-processing deficit in schizophrenics and their relatives and its association with impaired smooth pursuit. Proc Natl Acad Sci USA 1999;96(8):4724–4729.
Cleghorn JM, Kaplan RD, Nahmias C, Garnett ES, Szechtman H, Szechtman B. Inferior parietal region implicated in neurocognitive impairment in schizophrenia. Arch Gen Psychiatry 1989;46(8):758–760.
Condray R, Steinhauer SR, van Kammen DP, Kasparek A. Working memory capacity predicts language comprehension in schizophrenic patients. Schizophr Res 1996;20(1-2):1–13.
Crawford TJ, Sharma T, Puri BK, Murray RM, Berridge DM, Lewis SW. Saccadic eye movements in families multiply affected with schizophrenia: the Maudsley family study. Am J Psychiatry 1998; 155(12): 1703–1710.
Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Lyons MJ, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychol 1995;104(2):286–304.
Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysi-ological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997;94(2):587–592.
Gold JM, Hermann BP, Randolph C, Wyler AR, Goldberg TE, Weinberger DR. Schizophrenia and temporal lobe epilepsy: a neuropsychological analysis. Arch Gen Psychiatry 1994;51(4):265–272.
Goldberg TE, Ragland JD, Torrey EF, Gold JM, Bigelow LB, Weinberger DR. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 1990;47(11): 1066–1072.
Green MF, Nuechterlein KH, Breitmeyer B. Backward masking performance in unaffected siblings of schizophrenic patients: evidence for a vulnerability indicator. Arch Gen Psychiatry 1997;54(5):465–472.
Gur RE, Resnick SM, Alavi A, et al. Regional brain function in schizophrenia. Arch Gen Psychiatry 1987;44:119–125.
Harrison PJ, McLaughlin D, Kerwin RW. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 1991; 337(8739):450–452.
Heckers S, Goff D, Schacter DL, et al. Functional imaging of memory retrieval in deficit Vs nondeficit schizophrenia. Arch Gen Psychiatry 1999;56(12):1117–1123.
Heckers S, Rauch SL, Goff D, Savage CR, Schacter DLFAJ, Alpert NM. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nature 1998;1(4):318–323.
Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry 1996;153(1):41–49.
Issa F, Gerhardt GA, Bartko JJ, et al. A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in cchizophrenia: I comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses. Psychiatry Res 1994;52(3): 237–249.
Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP. Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 1994;151(8):1234–1236.
Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpro-mazine. Arch Gen Psychiatry 1988;45:789–796.
Kendler KS, Diehl SR. The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 1993;19(2):261–285.
Kety SS. The significance of genetic factors in the etiology of schizophrenia: results from the national study of adoptees in Denmark. J Psychiatr Res 1987;21(4):423–429.
Kornhuber J, Mack-Burkhardt F, Riederer P, et al. [3H] MK-801 binding items in postmortem brain regions of schizophrenic patients. J Neural Transm 1989;77:231–236.
Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT Jr. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatry 2001;158(11): 1797–1808.
Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992;160:179–186.
Lidow MS, Goldman-Rakic PS. A common action of clozapine, haloperidol, and remoxipride on D1-and D2-dopaminergic receptors in the primate cerebral cortex. Proc Natl Acad Sci USA 1994;91(10): 4353–4356.
Mackay AV, Iversen LL, Rossor M, et al. Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 1982;39(9): 991–997.
McCarley RW, Shenton ME, O’Donnell BF, et al. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry 1993;50(3):190–197.
Memo M, Kleinman JE, Hanbauer I. Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. Science 1983;221(4617):1304–1307.
Nishikawa T, Takashima M, Toru M. Increased [3H] kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci Lett 1983;40(3): 245–250.
Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley GJ. Increased dopamine-receptor sensitivity in schizophrenia. Lancet 1978;2(8083): 223–226.
Pogue-Geile MF, Garrett AH, Brunke JJ, Hall JK. Neuropsychological impairments are increased in siblings of schizophrenic patients. Schizophr Res 1991;4:390.
Reynolds GP. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 1983;305(5934):527–529.
Rosenthal R, Bigelow LB. Quantitative brain measurements in chronic schizophrenia. Br J Psychiatry 1972;121(562):259–264.
Ross DE, Thaker GK, Holcomb HH, Cascella NG, Medoff DR, Tamminga CA. Abnormal smooth pursuit eye movements in schizophrenic patients are associated with cerebral glucose metabolism in oculomotor regions. Psychiatry Res 1995;58(1):53–67.
Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA, Roberts RC. Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 2001;50(7):521–530.
Seeman P, Guan HC, Van Tol HH. Dopamine D4 receptors elevated in schizophrenia. Nature 1993;365(6445):441–445.
Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001;49(1-2): 1–52.
Shirakawa O, Tamminga CA. Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat. ExpNeurol 1994;127(1):62–69.
Silbersweig DA, Stern E, Frith C, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995;378(6553): 176–179.
Stevens AA, Goldman-Rakic PS, Gore JC, Fulbright RK, Wexler BE. Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging. Arch Gen Psychiatry 1998;55(12):1097–1103.
Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 1990;322(12):789–794.
Tamminga CA. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 1998;12(1,2):21–36.
Tamminga CA, Thaker GK, Buchanan R, et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992;49(7):522–530.
Thaker GK, Ross DE, Cassady SL, et al. Smooth pursuit eye movements to extraretinal motion signals: deficits in relatives of patients with schizophrenia. Arch Gen Psychiatry 1998;55(9):830–836.
Toru M, Watamabe S, Shibuya H, et al. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand 1988;78:121–137.
Tsuang MT, Woolson RF, Fleming JA. Long-term outcome of major psychoses. I. schizophrenia and affective disorders compared with psy-chiatrically symptom-free surgical conditions. Arch Gen Psychiatry 1979;36(12):1295–1301.
Ulas J, Cotman CW. Excitatory amino acid receptors in schizophrenia. Schizophr Bull 1993;19(1):105–117.
Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glu-tamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000;57:237–245.
Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 1992;149(7):890–897.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this chapter
Cite this chapter
Tamminga, C.A., Medoff, D.C., Thaker, G. (2006). Schizophrenia. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-963-9_128
Download citation
DOI: https://doi.org/10.1007/978-1-59259-963-9_128
Publisher Name: Humana Press
Print ISBN: 978-1-58829-202-5
Online ISBN: 978-1-59259-963-9
eBook Packages: MedicineMedicine (R0)